| Q28346472 | Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo |
| Q35041820 | Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism |
| Q43822317 | Changes in NOS activity and protein expression during acute and prolonged ANG II administration |
| Q44499356 | Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT. |
| Q42710940 | Endothelial dysfunction in the outer medullary vasa recta as a key to contrast media-induced nephropathy |
| Q37375868 | Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition |
| Q42589268 | Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production |
| Q47352438 | Free radical scavenging reverses fructose-induced salt-sensitive hypertension |
| Q47905993 | Glomerular and tubular effects of nitric oxide (NO) are regulated by angiotensin II (Ang II) in an age-dependent manner through activation of both angiotensin receptors (AT1Rs and AT2Rs) in conscious lambs. |
| Q92826928 | Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review |
| Q58143941 | Oxygen delivery and consumption in surfactant-depleted newborn piglets |
| Q35874069 | Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide |
| Q37629176 | Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging |
| Q34730417 | Sustained resveratrol infusion increases natriuresis independent of renal vasodilation |
| Q33712836 | Variants in genes involved in functional pathways associated with hypertension in African Americans |